Targeting the CB2 cannabinoid receptor in osteoporosis

References

• Bab I, Hajbi-Yonissi C, Gabet Y, Müller R. Micro-tomographic Atlas of the Mouse Skeleton. Springer, NY, USA, 195–199 (2007).
   Google Scholar
• Cauley J, Bulstra S. Mortality greater for hip fracture than breast cancer in elderly women. Presented at: American Geriatrics Society Annual Meeting. Seattle, WA, USA, 2–6 May 2007.
   Google Scholar
• Papapoulos SE. Use of bisphosphonates in the management of postmenopausal osteoporosis. Ann. NY Acad. Sci.1218(1), 15–32 (2011).
   Google Scholar
• Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat. Rev. Endocrinol.7(1), 34–42 (2011).
   PubMed Web of Science ®Google Scholar
• Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis. J. Clin. Endocrinol. Metab.95(4), 1555–1565 (2010).
   PubMed Web of Science ®Google Scholar
• Sellmeyer DE. Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA304(13), 1480–1484 (2010).
   PubMed Web of Science ®Google Scholar
• Cosman F. Parathyroid hormone treatment for osteoporosis. Curr. Opin. Endocrinol. Diabetes Obes.15(6), 495–501 (2008).
   PubMed Web of Science ®Google Scholar
• Cosman F. Anabolic therapy for osteoporosis: parathyroid hormone. Curr. Rheumatol. Rep.8(1), 63–69 (2006).
   PubMedGoogle Scholar
• Compston JE. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone40(6), 1447–1452 (2007).
   PubMed Web of Science ®Google Scholar
• Bab I, Zimmer A, Melamed E. Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Ann. Med.41(8), 560–567 (2009).
   PubMed Web of Science ®Google Scholar
• Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev.60(1), 255–266 (2009).
   PubMedGoogle Scholar
• Mach F, Steffens S. The role of the endocannabinoid system in atherosclerosis. J. Neuroendocrinol.20(Suppl. 1), 53–57 (2008).
   Google Scholar
• Mallat A, Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am. J. Physiol. Gastrointest. Liver Physiol.294(1), G9–G12 (2008).
   PubMed Web of Science ®Google Scholar
• Mallat A, Lotersztajn S. Endocannabinoids and their role in fatty liver disease. Dig. Dis.28(1), 261–266 (2010).
   PubMedGoogle Scholar
• Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol.160(3), 467–479 (2010).
   PubMed Web of Science ®Google Scholar
• Tam J, Trembovler V, Di Marzo V et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J.22(1), 285–294 (2008).
   PubMed Web of Science ®Google Scholar
• Cravatt BF, Demarest K, Patricelli MP et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA98(16), 9371–9376 (2001).
   PubMed Web of Science ®Google Scholar
• Rossi F, Siniscalco D, Luongo L et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone44(3), 476–484 (2009).
   PubMed Web of Science ®Google Scholar
• Ofek O, Karsak M, Leclerc N et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl Acad. Sci. USA103(3), 696–701 (2006).
   PubMed Web of Science ®Google Scholar
• Tam J, Ofek O, Fride E et al. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol. Pharmacol.70(3), 786–792 (2006).
   PubMed Web of Science ®Google Scholar
• Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br. J. Pharmacol.153(2), 182–188 (2008).
   PubMed Web of Science ®Google Scholar
• Smoum R, Bar A, Tan B et al. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc. Natl Acad. Sci. USA107(41), 17710–17715 (2010).
   PubMedGoogle Scholar
• Ofek O, Attar-Namdar M, Kram V et al. CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. J. Bone Miner. Res.26(2), 308–316 (2011).
   Google Scholar
• Bab I. The skeleton: stone bones and stoned heads? In: Cannabinoids as Therapeutics. Milestones in Drug Therapy Series. Mechoulam R (Ed.). Birkhäuser Verlag, Basel, Switzerland, 201–206 (2005).
   Google Scholar
• George KL, Saltman LH, Stein GS, Lian JB, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J. Cell Physiol.214(3), 714–720 (2008).
   PubMed Web of Science ®Google Scholar
• Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A. Endocannabinoids and the regulation of bone metabolism. J. Neuroendocrinol.20(Suppl. 1), 69–74 (2008).
   PubMed Web of Science ®Google Scholar
• Smoum R, Breuer A, Hanuš L et al. HU-433, Enantiomer of the CB2 agonist HU-308 is a highly potent regulator of bone mass. Presented at: 20th Annual Symposium of the International Cannabinoid Research Society. Lund, Sweden, 23–27 July 2010.
   Google Scholar
• Sophocleous A, Landao-Bassongaa E, van’t Hof R, Ralston S, Idris A. The type 2 cannabinoid receptor (CB2) protects against age-related osteoporosis by affecting bone formation and CB2 agonists exhibit anabolic activity in vivo. Presented at: 36th European Symposium on Calcified Tissues of the ECTS. Vienna, Austria, 23–27 May 2009.
   Google Scholar
• Devoto M, Spotila LD, Stabley DL et al. Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density. Eur. J. Hum. Genet.13(6), 781–788 (2005).
   PubMedGoogle Scholar
• Karsak M, Cohen-Solal M, Freudenberg J et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet.14(22), 3389–3396 (2005).
   PubMed Web of Science ®Google Scholar
• Karsak M, Malkin I, Toliat MR et al. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample. Hum. Genet.126(5), 629–636 (2009).
   PubMed Web of Science ®Google Scholar
• Huang QY, Li GH, Kung AW. Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese. Bone44(5), 984–988 (2009).
   Google Scholar
• Yamada Y, Ando F, Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med.19(5), 791–801 (2007).
   PubMedGoogle Scholar